Cogent Biosciences Inc (COGT)
8.91
-0.74
(-7.67%)
USD |
NASDAQ |
Nov 15, 16:00
9.27
+0.36
(+4.04%)
After-Hours: 16:55
Cogent Biosciences Market Cap: 975.20M for Nov. 15, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 14, 2024 | 1.056B |
| November 13, 2024 | 1.138B |
| November 12, 2024 | 1.136B |
| November 11, 2024 | 1.138B |
| November 08, 2024 | 1.117B |
| November 07, 2024 | 1.100B |
| November 06, 2024 | 1.147B |
| November 05, 2024 | 1.093B |
| November 04, 2024 | 1.299B |
| November 01, 2024 | 1.283B |
| October 31, 2024 | 1.258B |
| October 30, 2024 | 1.315B |
| October 29, 2024 | 1.313B |
| October 28, 2024 | 1.301B |
| October 25, 2024 | 1.310B |
| October 24, 2024 | 1.315B |
| October 23, 2024 | 1.346B |
| October 22, 2024 | 1.340B |
| October 21, 2024 | 1.298B |
| October 18, 2024 | 1.302B |
| October 17, 2024 | 1.274B |
| October 16, 2024 | 1.242B |
| October 15, 2024 | 1.277B |
| October 14, 2024 | 1.238B |
| October 11, 2024 | 1.231B |
| Date | Value |
|---|---|
| October 10, 2024 | 1.214B |
| October 09, 2024 | 1.182B |
| October 08, 2024 | 1.188B |
| October 07, 2024 | 1.175B |
| October 04, 2024 | 1.216B |
| October 03, 2024 | 1.155B |
| October 02, 2024 | 1.173B |
| October 01, 2024 | 1.177B |
| September 30, 2024 | 1.182B |
| September 27, 2024 | 1.193B |
| September 26, 2024 | 1.193B |
| September 25, 2024 | 1.191B |
| September 24, 2024 | 1.197B |
| September 23, 2024 | 1.166B |
| September 20, 2024 | 1.202B |
| September 19, 2024 | 1.193B |
| September 18, 2024 | 1.155B |
| September 17, 2024 | 1.151B |
| September 16, 2024 | 1.184B |
| September 13, 2024 | 1.163B |
| September 12, 2024 | 1.124B |
| September 11, 2024 | 1.172B |
| September 10, 2024 | 1.169B |
| September 09, 2024 | 1.198B |
| September 06, 2024 | 1.146B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.564M
Minimum
Mar 16 2020
1.346B
Maximum
Oct 23 2024
526.47M
Average
386.91M
Median
Dec 21 2020
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 3.371M |
| Palatin Technologies Inc | 18.00M |
| iBio Inc | 19.78M |
| Theriva Biologics Inc | 1.387M |
| Oragenics Inc | 1.790M |
Market Cap Related Metrics
| PS Ratio | 35.30 |
| PEG Ratio | -0.0764 |
| Price to Book Value | 3.764 |
| Price | 8.91 |
| Earnings Yield | -27.83% |
| PEGY Ratio | -0.0764 |